Iatriko Diavalkaniko Thessalonikis

Thessaloniki 57001

1 studies enrolling now · 3 studies all time

What they study most

Chemotherapy-induced Thrombocytopenia, Extensive Stage Small-cell Lung Cancer, Small Cell Lung Cancer, Small-cell Lung Cancer

Studies at this site

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) — Running, not enrolling
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer — Running, not enrolling